Serum CA 125 concentrations have been measured in 115 patients with histologically confirmed nonmalignant pelvic disease, that is, serous cystadenoma (n = 56), mucinous cystadenoma (n = 14), fibroma (n = 33), thecoma (n = 8), and Brenner tumour (n = 4). Increased CA 125 concentrations (>35 KU/L) wer
β¦ LIBER β¦
Benign conditions associated with raised serum CA-125 concentration
β Scribed by Paul Buamah
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 78 KB
- Volume
- 75
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Serum CA 125 concentrations in patients
β
Dr. Paul K. Buamah; Andrew W. Skillen
π
Article
π
1994
π
John Wiley and Sons
π
English
β 311 KB
Value of FDG PET/CT in Patients with Tre
β
Azahara Palomar; Cristina Nanni; Paolo Castellucci; Valentina Ambrosini; Gian Ca
π
Article
π
2011
π
Springer-Verlag
π
English
β 339 KB
Serum concentrations of CA 125 and amino
β
CΗndido TomΓ‘s; Jorma Penttinen; Juha Risteli; Leila Risteli; Juhani Vuori; Antti
π
Article
π
1990
π
John Wiley and Sons
π
English
β 695 KB
Association between serum levels of solu
β
Robert A. Burger; Kathleen M. Darcy; Philip J. DiSaia; Bradley J. Monk; Elizabet
π
Article
π
2004
π
John Wiley and Sons
π
English
β 209 KB
π 1 views
## Abstract ## BACKGROUND A prospective study was undertaken within the Gynecologic Oncology Group to determine whether serum levels of soluble tumor necrosis factor receptors I (sTNFRβI) and II (sTNFRβII), alone or in combination with CA 125, were associated with clinicopathologic characteristics